David Watumull - Cardax Insider

CDXI -- USA Stock  

USD 0.19  0.02  9.52%

  VP
Mr. David M. Watumull is Chief Operating Officer, Assistant Treasurer, Assistant Secretary of the Cardax, Inc. Mr. Watumull has served as Vice President, Operations of Pharma since its inception in May 2013, Assistant Treasurer and Assistant Secretary of Pharma since July 2013, and Secretary and Treasurer of Pharma from its inception in May 2013 to July 2013. Mr. Watumull has served as Vice President, Operations, Assistant Treasurer, and Assistant Secretary of Holdings since July 2013, and previously as Director, Operations and Finance from 2009 to 2013, Operations Manager from 2008 to 2009, and Program Manager from its inception in 2006 to 2009. Mr. Watumull heads daytoday company operations related to accounting, banking, budgeting, leasing, insurance, debtequity transactions and due diligence, capitalization structure, reporting, corporate governance, contracting and related legal matters, intellectual property, human resources, front office, facilities and equipment, and information technology. Mr. Watumull also manages the relationships, timelines, and budgets of development partners, contractors, and regulatory consultants associated with the production and testing of Cardax products. Mr. Watumull was previously Program Manager at Hawaii Biotech, Inc. from 2005 to 2006, Project Coordinator from 2004 to 2005, and Information Technology Associate Manager from 2002 to 2004. Mr. Watumull also worked at Aquasearch, Inc. from 2000 to 2001 in various capacities including Medical Information Specialist and Information Technology Associate. Mr. Watumull graduated first in his high school class and studied Electrical Engineering at the University of Hawaii
Age: 34  VP Since 2017      
808-457-1400  http://www.cardaxpharma.com
Watumull was Executive Vice President of Aquasearch, Inc., a public astaxanthin consumer health company, from 1998 to 2000. From 1997 to 1998 he headed his own biotech research firm, Watumull & Co. From 1994 to 1997 he was a biotech research analyst, money manager, and investment banker at First Honolulu Securities. From 1992 to 1994 he led his own money management firm, Biovest, Inc. Prior to that, from 1982 to 1992, Mr. Watumull worked at Paine Webber in various capacities, including as a biotech money manager and investment executive.

Management Efficiency

The company has return on total asset (ROA) of (111.6) % which means that it has lost $111.6 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (12.0) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Found 1 records

VP Since

John ToddFiesta Restaurant Group
2015

Entity Summary

Cardax, Inc., a life sciences company, develops and commercializes consumer health and pharmaceutical products for anti-inflammatory benefits primarily in Hawaii. Cardax, Inc. was incorporated in 2012 and is based in Honolulu, Hawaii. Cardax operates under Biotechnology classification in USA and traded on BATS Exchange. It employs 11 people.Cardax [CDXI] is traded as part of a regulated electronic over-the-counter service offered by the NASD. Cardax is listed under Restaurants Hotels Motels category by Fama And French industry classification.

Cardax Leadership Team

George Bickerstaff, Independent Director
Nicholas Mitsakos, Executive Chairman
Richard Morris, Secretary
Tamar Howson, Independent Director
Gilbert Shin, Vice President - Retail Sales and Marketing
Elona Kogan, Independent Director
Frank Herringer, Director
Makarand Jawadekar, Independent Director
Terence Kelly, Independent Director
David Watumull, VP of Operations, Assistant Treasurer and Assistant Secretary
Michele Galen, Independent Director
John Russell, CFO, Treasurer

Stock Performance Indicators

Current Sentiment - CDXI

Cardax Investor Sentiment

Most of Macroaxis users are currently bullish on Cardax. What is your opinion about investing in Cardax? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Cardax Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Cardax and Biglari Holdings. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Search macroaxis.com